| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > Secrets to Effective Staff Meetings |
|
E-Folder - Secrets to Effective Staff Meetings
The following typical staff meeting statistics were compiled from a Survey conducted by GroupSystems : The typical staff meeting is 50 minutes - 16 minut According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product es wasted on inefficiencies - 59% do not take meeting minutes -68% said input from meeting is used rarely or not at all What can you do about it? ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in Schedule in advance. If it is not an emergency, schedule one to two weeks in advance. Include start time, stop time and Topics. Prepare an Agenda, and stick lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. to it. Have a Theme . Focus on One to Three Topics, no more than that. On the Agenda, include ten minutes for Open Discussion and feedback at the end of the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe meeting. Start on Time, even if everyone is not present. Demonstrate respect for the people who show up on time and begin promptly. Individuals that come late d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro can 'catch-up' when the meeting is concluded. Do not inconvenience the conscientious individuals who show up on time. Establish the meeting moderator. One pers ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc on is assigned to keep the meeting on track and on time. If possible, schedule the staff meeting for a total of twenty minutes or less. This is based on ten mi easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi utes of Agenda discussion and ten minutes of staff feedback. Consider it a success if you conclude in less than 20 minutes, but allow flex time for meaningful c nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically onversation and feedback at the end of the meeting. Take Meeting Notes, include Action Items and the Owners / Responsible Person for each Action Item with a Du and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e Date. Follow-up on Action Items and send out an update before the next staff meeting. Is it working? Staff Meetings should not be a burden to the moderator ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi or the participants. It is intended to be an opportunity for important communication. The following are three creative exercises for measuring the effectiveness ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a of your staff meetings. Have a Standing Staff Meeting: Nobody is allowed to sit down until it is over. Can you do it? Does the meeting move along faster than dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod normal or at the same speed? Everyone is a Scribe: At the beginning of the meeting, provide instructions that each person will be responsible for documenting e cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin very comment, word for word, and distribute to the other participants. How does this impact the comments? Is everything shared verbally worth the time to type i tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ? Are the comments worth sharing in documented form? Are there any comments shared in a staff meeting that would be embarrassing or inappropriate in print? Th t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e One Week Survey: Send a quick survey one week after the staff meeting with three questions. Q1) What was the main topic of the Staff meeting? Q2) How does t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust his relate to your responsibilities? Q3) What is the most important topic that we did not discuss? ______________________________________________________ y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products Words of Wisdom "You want to build a strong culture? Hold every manager accountable for the culture that he or she builds." - Marcus Buckingham and Curt . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de Coffman, First Break All the Rules "The real problem is that people do what they are told." - David Maister, First Among Equals "Being highly effective elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip as individuals and organizations is no longer optional . . . it is the price of entry." - Stephen R. Covey, The 8th Habit: From Effectiveness to Greatnes tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Image and Branding Advertising-Get over it or Go Broke! Business Growth - The New Rules For Bringing Innovations To Market
|